Coumarin

Coumarin

SCHEMBL2301559

C.O=c1ccc2ccccc2o1

nearest known ligand 0.95

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 11/20 0.95
CA9 Q16790 11/20 0.95
CA1 P00915 7/20 0.95
CA3 P07451 7/20 0.95
CA4 P22748 7/20 0.95
CA7 P43166 7/20 0.95
CA14 Q9ULX7 7/20 0.95
CA5A P35218 6/20 0.95
CA6 P23280 6/20 0.95
CA5B Q9Y2D0 5/20 0.95
CA2 P00918 5/20 0.95
MCL1 Q07820 4/20 0.95
TDP1 Q9NUW8 3/20 0.95
LMNA P02545 3/20 0.95
SOST Q9BQB4 1/20 0.95
PGR P06401 2/20 0.55
ALDH1A1 P00352 5/20 0.52
HPGD P15428 5/20 0.52
HSD17B10 Q99714 4/20 0.52
KDM4E B2RXH2 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Coumarin SCHEMBL29385611 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL6252 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL28886137 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL1038138 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL621751 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL3441294 0.98 CA12 (1.00) CA12CA9CA1CA3CA4
Coumarin SCHEMBL8004826 0.95 CA12 (0.95) CA12CA9CA1CA3CA4
Coumarin SCHEMBL531571 0.95 CA12 (0.95) CA12CA9CA1CA3CA4
Coumarin SCHEMBL22721260 0.95 CA12 (0.95) CA12CA9CA1CA3CA4
Coumarin SCHEMBL9643642 0.95 CA12 (0.95) CA12CA9CA1CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110272399-A The method of biomass-based furfuryl alcohol derivative green high-efficient synthesis Coumarin methane 诸暨市瀚海环保科技有限公司 2019-09-24 CN claimed
CN-110483460-B Preparation method of 3-seleno-coumarin compound 温州医科大学 2021-04-20 CN disclosed
CN-110831969-A Methods of treating or ameliorating metabolic disorders using a combination of a Gastric Inhibitory Peptide Receptor (GIPR) binding protein and a GLP-1 agonist 安进公司 2020-02-21 CN disclosed
CN-110437182-A A method of BMFM is synthesized from 5-MFA green high-efficient UNIV NANCHANG 2019-11-12 CN disclosed
CN-110272399-A The method of biomass-based furfuryl alcohol derivative green high-efficient synthesis Coumarin methane 诸暨市瀚海环保科技有限公司 2019-09-24 CN disclosed
CN-110272399-A The method of biomass-based furfuryl alcohol derivative green high-efficient synthesis Coumarin methane 诸暨市瀚海环保科技有限公司 2019-09-24 CN disclosed
CN-110272399-A The method of biomass-based furfuryl alcohol derivative green high-efficient synthesis Coumarin methane 诸暨市瀚海环保科技有限公司 2019-09-24 CN disclosed
US-8313920-B2 High-throughput assay for evaluating dipeptidyl peptidase I activity JANSSEN RESEARCH & DEVELOPMENT, LLC (US) 2012-11-20 US disclosed
EP-2350310-A1 HIGH-THROUGHPUT ASSAY FOR EVALUATING DIPEPTIDYL PEPTIDASE I ACTIVITY Johnson & Johnson Pharmaceutical Research & Development L.L.C. (US) 2011-08-03 EP disclosed
US-20100136594-A1 HIGH-THROUGHPUT ASSAY FOR EVALUATING DIPEPTIDYL PEPTIDASE I ACTIVITY JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC (US) 2010-06-03 US disclosed
WO-2010048306-A1 HIGH-THROUGHPUT ASSAY FOR EVALUATING DIPEPTIDYL PEPTIDASE I ACTIVITY JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) 2010-04-29 WO disclosed